Advertisement

Topics

Novo A/S Company Profile

21:23 EDT 18th June 2018 | BioPortfolio

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed and independently operating companies Novo Nordisk A/S and Novozymes A/S.Novo A/S was established to manage the Foundation's funds and to invest actively in other companies. We invest in companies that are or will become successful, and we actively support the individual company in achieving its own goals.

Location

Krogshoejvej 41
Bagsvaerd
DK-2880
Denmark

Contact

Phone: 45 88 24 88 24
Fax: 45 88 24 88 20
Email: novocontact@novo.dk


News Articles [442 Associated News Articles listed on BioPortfolio]

Novo Nordisk: Passende Übernahme

Die Analysten der UBS bestätigen die Kaufempfehlung für die Aktien von Novo Nordisk aus Dänemark. Das Kursziel für die Papiere von Novo Nordisk sehen die Experten weiter bei 370,00 DKK. Die Dänen...

Ablynx Rejects Novo Nordisk’s $3.1 Billion Acquisition Proposal

GHENT, Belgium, 8 January 2018 – Ablynx NV (Euronext Brussels and Nasdaq: ABLX) (“Ablynx” or the “Company”) today confirmed that on December 22, 2017 it received an unsolicited condition...

Ablynx’ Stock Jumps by 60% After Rejecting Acquisition from Novo Nordisk

Ablynx has rejected a generous acquisition offer from Novo Nordisk. As a result, its stock has soared and is now worth more than what Novo offered in the first place. Early this morning, Novo Nordisk...

Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance

Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing new drugs to overcome antibiotic resistance. Novo Holdings is the venture capital arm of the Danish b...

Novo Nordisk Aktie: Novo Nordisk nimmt neue Märkte ins Visier!

Liebe Leser, Novo Nordisk ist den meisten Anlegern aufgrund seiner Diabetes-Medikamente bekannt. Bekanntlich ist es jedoch nie eine gute Idee, all sein Geld auf ein einziges Pferd zu setzen. Deshal...

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Novo Nordisk, Sucampo Pharma, ...

www.wallstequities.com/registration Novo Nordisk On Thursday, shares in Bagsvaerd, Denmarkheadquartered Novo Nordisk A/S recorded a trading volume of 2.22 million shares, which was above their R...

Sanofi outbids Novo with €45 per share offer for Ablynx, total of €3.8bn

Public Belgian biotech Ablynx NV agreed to be acquired by Sanofi, which offered €45 per share ($59.92; a 37% premium) for a fully diluted equity value of €3.8bn ($5.1bn). The deal trumps an offer ...

Novo Nordisk: Über dem Kursziel

Die Analysten von Bernstein bestätigen das Rating "market perform" für die Aktien von Novo Nordisk. Das Kursziel für die Aktien der Dänen sehen die Experten wie bisher bei 320,00 DKK. Bei Novo Nor...

Drugs and Medications [25 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Physicians Total Care, Inc.]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

R HUMAN Novolin R Regular, Human Insulin Injection (recombinant DNA origin) USP 100 units/mL

PubMed Articles [268 Associated PubMed Articles listed on BioPortfolio]

The complete mitochondrial genome of the Dutch elm disease fungus Ophiostoma novo-ulmi subspecies novo-ulmi.

Ophiostoma novo-ulmi, a member of the Ophiostomatales (Ascomycota) is the causal agents of the current Dutch elm disease pandemic in Europe and North America. The complete mitochondrial genome (mtDNA)...

A molecular portrait of de novo genes in yeasts.

New genes, with novel protein functions, can evolve "from scratch" out of intergenic sequences. These de novo genes can integrate the cell's genetic network and drive important phenotypic innovations....

On the possibility of death of new genes - evidence from the deletion of de novo microRNAs.

New genes are constantly formed, sometimes from non-genic sequences, creating what is referred to as de novo genes. Since the total number of genes remains relatively steady, gene deaths likely balanc...

Grouper: Graph-based clustering and annotation for improved de novo transcriptome analysis.

De novo transcriptome analysis using RNA-seq offers a promising means to study gene expression in non-model organisms. Yet, the difficulty of transcriptome assembly means that the contigs provided by ...

The ascent of man(made oxidoreductases).

Though established 40 years ago, the field of de novo protein design has recently come of age, with new designs exhibiting an unprecedented level of sophistication in structure and function. With resp...

Clinical Trials [355 Associated Clinical Trials listed on BioPortfolio]

Evaluating Therapeutic Response to Novo-TTF

This study is to assess the utility of high resolution 3D echo planar magnetic resonance spectroscopy (3D EPSI) in monitoring Novo-TTF response in glioblastoma multiforme (GBM) patients.

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

The study will enroll patients with angiographically significant coronary de novo lesions. Subjects will be randomized 1:1 and treated with a Lutonix catheter either before or after bare-m...

Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients

Individuals with resolved hepatitis B, characterized as hepatitis B surface antigen (HBsAg)-negative and hepatitis B core antibody-positive, have latent hepatitis B virus (HBV) infection i...

De Novo Lipogenesis of Sebaceous Glands in Acne

There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. ...

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (trivalent, seasonal influenza vaccine, active ingredient content: 6 μg HA/strain/0.5 ml) for Children and...

Companies [55 Associated Companies listed on BioPortfolio]

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

NOVO Engineering

NOVO engineering (www.NOVOengineering.com) is a leading privately held design engineering firm whose team of world-class engineers has been exceeding clients’ needs since 199...

NOVO 1

Since 1987, NOVO 1 has been dedicated to tailoring contact center solutions to support clients’ business goals in building customer relationships and growing their brands. NO...

More Information about "Novo A/S" on BioPortfolio

We have published hundreds of Novo A/S news stories on BioPortfolio along with dozens of Novo A/S Clinical Trials and PubMed Articles about Novo A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novo A/S Companies in our database. You can also find out about relevant Novo A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record